반응식
[NH:1]1[CH2:6][CH2:5][O:4][CH2:3][CH:2]1[C:7]([OH:9])=O.N[C@H](CC)C(O)=O.N[C@H](CC)C(OC)=O.CO[C:27]([CH:29]1[CH2:34]OC[CH2:31][NH:30]1)=O.[Cl:35][C:36]1[N:41]=C(Cl)C([N+]([O-])=O)=C[N:37]=1.ClC1N=C(N(C2CCCC2)[C@H](CC)C(OC)=O)C([N+]([O-])=O)=CN=1>>[Cl:35][C:36]1[N:41]=[CH:34][C:29]2[N:30]([CH3:31])[C:7](=[O:9])[CH:2]3[CH2:3][O:4][CH2:5][CH2:6][N:1]3[C:27]=2[N:37]=1참가 물질
7
반응물 6
생성물 1
실험 절차
Intermediate I was prepared in the same manner as Intermediate B, using 3-morpholinecarboxylic acid as the starting material instead of (R)-2-aminobutanoic acid. No reductive amination step, such as that used for the conversion of compound II to compound III, was required. Rather, methylmorpholine-3-carboxylate was reacted directly with 2,4-dichloro-5-nitropyrimidine in the same manner as is described for the conversion of compound III to Intermediate A. LCMS: 254.9 m/z (M+H)+.
출처 및 근거
- ORD 기록
- ord-7a344267664e4517b6f16e4125cc4cfa
- 출처 데이터셋
- uspto-grants-2013_09
- 특허 번호
- US08541418B2
연결된 노트
불러오는 중…